PPT-Module 5: Additional Complications of CKD

Hyperkalemia Metabolic Acidosis Malnutrition Depression amp Acute Kidney Injury Andrew Narva MD FASN amp Amy Barton Pai PharmD MHI FASN FCCP FNKF Andrew Narva MD FASN. Program Goals. Hepcidin in Chronic Kidney Disease. Treatment of Iron Deficiency Anemia. Assessment of IV Iron in Patients With Non-Dialysis-Dependent CKD. DOPPS Study. Ferric Pyrophosphate. Phosphate Binders. . with. . chronic. . kidney. . disease. Gülçin Kantarcı, M.D.. Nephrology Department. Learning . objectives. . and. . training. . goals. of . this. . lecture. Define chronic kidney disease. . (HCC Coding). Payment Model. General. Education Guide. 1. What is CMS’s . Hierarchical Condition Categories. ?. Medicare Risk Adjustment. payment model introduced by the Centers for Medicare and Medicaid (CMS) in 2004.. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2007–2012 participants aged 20 & older. Whisker lines indicate 95% confidence intervals. Abbreviations: CKD, chronic kidney disease. This graphic also appears as Figure 1.2. Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. No financial disclosures/conflicts of interest. Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Lowell Dilworth-Chemical Pathologist. CKD. CKD and Bone disease. Mineral . metabolism controlled by kidneys. , intestine, parathyroid glands and . bone. The . kidney plays a critical role in mineral homeostasis regulation and, therefore, renal disease exerts widespread effects on the skeleton and soft . Definition of CKD. Staging of CKD. Etiology of CKD. How to measure Kidney function . Incidence of ESRD. (per million population, 1990, by HSA, unadjusted). USRDS, 2000. Incidence of ESRD. (per million population, 2000, by HSA, unadjusted) . KDIGO Guideline Co-Chairs:. Alfred K. Cheung, MD. Johannes F.E. Mann, MD. Guideline: . Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1–S87. KDIGO 2017 Clinical Practice Guideline Update. Speaker’s Guide. Summary of KDIGO CKD-MBD Guideline Recommendations. This Speaker’s Guide combines the new recommendation statements . (noted in green) . Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . Narender Goel et al.. Middletown Medical PC,. Montefiore Medical Center & Albert Einstein College of . Medicine, New York. 4th International Conference on Nephrology & Therapeutics. September . Harshani D. Perera . Senior Registrar – Nephrology. SJGH . 09.01.2018. CKD – definition . Kidney damage or eGFR < 60 ml/min/1.73m2 persisting for 3 months despite the cause . several classifications . .. สุดารัตน์ . ศุภ. กิจเจริญ. หน่วยงานวิสัญญี โรงพยาบาลกำแพงเพชร. Etiology of CKD. In UK , most common causes are;. Kidney Specialists, Inc.. National Kidney Foundation of Central Ohio. Board of Advisors. Medical Advisory Board. Goals of this talk:. Teach providers how to evaluate CKD patients in their office, to start the diagnostic and treatment plan.